A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Pro-gun protesters met Barack Obama in Oregon as he arrived to console victims and affected families of the community college shooting.
A grandmother has been jailed for repeatedly stabbing her 5-year-old grandson because he didn't give her the remote control.
A lonely hearts fraudster who conned five women - including an elderly widow - out of nearly £200,000 has been jailed for eight years.